Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation

Journal of Virology

Volumn 85, Issue 14, 2011, Pages 7465-7471

  Avdic, Selmir ^a   Cao, John Z ^a   Cheung, Allen K L ^a   Abendroth, Allison ^a   Slobedman, Barry ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; DISEASE COURSE; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOMODULATION; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; UL111A GENE; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS LATENCY; VIRUS LOAD;

BASE SEQUENCE; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; DNA PRIMERS; HUMANS; INTERLEUKIN-10; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

HUMAN HERPESVIRUS 5;

EID: 79960418128     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00088-11     Document Type: Article

References (63)

1. Anton, D., S. Dabadghao, K. Palucka, G. Holm, and Q. Yi. 1998. Generation of dendritic cells from peripheral blood adherent cells in medium with human serum. Scand. J. Immunol. 47:116-121.
2. Bego, M., J. Maciejewski, S. Khaiboullina, G. Pari, and S. St. Jeor. 2005. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79:11022-11034.
3. Burns, S., et al. 2004. Maturation of DC is associated with changes in motile characteristics and adherence. Cell Motil. Cytoskeleton 57:118-132.
4. Caux, C., et al. 1999. Respective involvement of TGF-beta and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors. J. Leukoc. Biol. 66:781-791.
5. Chang, W. L., P. A. Barry, R. Szubin, D. Wang, and N. Baumgarth. 2009. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390:330-337.
6. Chang, W. L., N. Baumgarth, D. Yu, and P. A. Barry. 2004. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. J. Virol. 78:8720-8731.
7. Cheeran, M. C., S. Hu, W. S. Sheng, P. K. Peterson, and J. R. Lokensgard. 2003. CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. J. Virol. 77:4502-4515.
8. Cheung, A. K., A. Abendroth, A. L. Cunningham, and B. Slobedman. 2006. Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108:3691-3699.
9. Cheung, A. K., et al. 2009. The role of the human cytomegalovirus UL111A gene in downregulating CD4+ T cell recognition of latently infected cells: implications for virus elimination during latency. Blood 114:4128-4137.
10. Choi, G. S., J. M. Kang, and M. G. Lee. 2000. Analysis of methods for the generation of dendritic cells from human peripheral blood monocytes. Yonsei Med. J. 41:642-650.
11. De La Melena, V. T., et al. 2001. Kinetics and development of CMV-accelerated transplant vascular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus. Transplant. Proc. 33:1822-1823.
12. Goodrum, F., C. T. Jordan, S. S. Terhune, K. High, and T. Shenk. 2004. Differential outcomes of human cytomegalovirus infection in primitive hematopoietic subpopulations. Blood 104:687-695.
13. Goodrum, F., M. Reeves, J. Sinclair, K. High, and T. Shenk. 2007. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937-945.
14. Hahn, G., R. Jores, and E. S. Mocarski. 1998. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl. Acad. Sci. U. S. A. 95:3937-3942.
15. Jaksits, S., et al. 1999. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J. Immunol. 163:4869-4877.
16. Jaworowski, A., et al. 2009. Enhanced monocyte Fc phagocytosis by a homologue of interleukin-10 encoded by human cytomegalovirus. Virology 391:20-24.
17. Jenkins, C., A. Abendroth, and B. Slobedman. 2004. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol. 78:1440-1447.
18. Jenkins, C., et al. 2008. Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J. Virol. 82:3736-3750.
19. Jonuleit, H., et al. 1997. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27:3135-3142.
20. Katz, S. I., K. Tamaki, and D. H. Sachs. 1979. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282:324-326.
21. Klechevsky, E., et al. 2008. Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells. Immunity 29:497-510.
22. Kondo, K., H. Kaneshima, and E. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. U. S. A. 91:11879-11883.
23. Kondo, K., J. Xu, and E. S. Mocarski. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. U. S. A. 93:11137-11142.
24. Kotenko, S. V., S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. U. S. A. 97:1695-1700.
25. Lin, Y. L., P. C. Chang, Y. Wang, and M. Li. 2008. Identification of novel viral interleukin-10 isoforms of human cytomegalovirus AD169. Virus Res. 131:213-223.
26. Lockridge, K. M., et al. 2000. Primate cytomegaloviruses encode and express an IL-10-like protein. Virology 268:272-280.
27. Mendelson, M., S. Monard, P. Sissons, and J. Sinclair. 1996. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77:3099-3102.
28. Minton, E. J., C. Tysoe, J. H. Sinclair, and J. G. Sissons. 1994. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68:4017-4021.
29. Mocarski, E. S., T. Shenk, and R. F. Pass. 2007. Cytomegaloviruses, p. 2701-2772. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2. Lippincott Williams & Wilkins, Philadelphia, PA.
30. Mollah, Z. U., et al. 2003. Interleukin-3 in cooperation with transforming growth factor beta induces granulocyte macrophage colony stimulating factor independent differentiation of human CD34+ hematopoietic progenitor cells into dendritic cells with features of Langerhans cells. J. Investig. Dermatol. 121:1397-1401.
31. O'Doherty, U., et al. 1994. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82:487-493.
32. Olweus, J., et al. 1997. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc. Natl. Acad. Sci. U. S. A. 94:12551-12556.
33. Pepperl-Klindworth, S., et al. 2006. Cytomegalovirus interleukin-10 expression in infected cells does not impair MHC class I restricted peptide presentation on bystanding antigen-presenting cells. Viral Immunol. 19:92-101.
34. Petrucelli, A., M. Rak, L. Grainger, and F. Goodrum. 2009. Characterization of a novel Golgi apparatus-localized latency determinant encoded by human cytomegalovirus. J. Virol. 83:5615-5629.
35. Pierre, P., et al. 1997. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388:787-792.
36. Raftery, M. J., et al. 2004. Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. Immunol. 173:3383-3391.
37. Reeves, M. B., P. A. MacAry, P. J. Lehner, J. G. Sissons, and J. H. Sinclair. 2005. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl. Acad. Sci. U. S. A. 102:4140-4145.
38. Reid, C. D., et al. 1990. Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood. Blood 76:1139-1149.
39. Reid, C. D., A. Stackpoole, A. Meager, and J. Tikerpae. 1992. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J. Immunol. 149:2681-2688.
40. Riedl, E., H. Strobl, O. Majdic, and W. Knapp. 1997. TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis. J. Immunol. 158:1591-1597.
41. Romani, N., et al. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
42. Romani, N., et al. 1989. Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J. Exp. Med. 169:1169-1178.
43. Romani, N., et al. 1996. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196:137-151.
44. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118.
45. Santiago-Schwarz, F., E. Belilos, B. Diamond, and S. E. Carsons. 1992. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J. Leukoc. Biol. 52:274-281.
46. Slobedman, B., P. A. Barry, J. V. Spencer, S. Avdic, and A. Abendroth. 2009. Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J. Virol. 83:9618-9629.
47. Slobedman, B., et al. 2010. Human cytomegalovirus latent infection and associated viral gene expression. Future Microbiol. 5:883-900.
48. Slobedman, B., and E. S. Mocarski. 1999. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73:4806-4812.
49. Soderberg-Naucler, C., K. N. Fish, and J. A. Nelson. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126.
50. + monocytes is differentiation dependent. J. Virol. 75:7543-7554.
51. Spencer, J. V. 2007. The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes. J. Virol. 81:2083-2086.
52. Spencer, J. V., J. Cadaoas, P. R. Castillo, V. Saini, and B. Slobedman. 2008. Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. Virology 374:164-169.
53. Stanier, P., et al. 1989. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ 299:897-898.
54. Stoitzner, P., et al. 2006. Langerhans cells cross-present antigen derived from skin. Proc. Natl. Acad. Sci. U. S. A. 103:7783-7788.
55. Strobl, H., et al. 1997. flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90:1425-1434.
56. Strobl, H., and W. Knapp. 1999. TGF-beta1 regulation of dendritic cells. Microbes Infect. 1:1283-1290.
57. Strobl, H., et al. 1996. TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors. J. Immunol. 157:1499-1507.
58. Taylor-Wiedeman, J., J. G. Sissons, L. K. Borysiewicz, and J. H. Sinclair. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:2059-2064.
59. Taylor-Wiedeman, J., P. Sissons, and J. Sinclair. 1994. Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol. 68:1597-1604.
60. Thomas, R., L. S. Davis, and P. E. Lipsky. 1993. Isolation and characterization of human peripheral blood dendritic cells. J. Immunol. 150:821-834.
61. Yamamoto-Tabata, T., S. McDonagh, H. T. Chang, S. Fisher, and L. Pereira. 2004. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J. Virol. 78:2831-2840.
62. Zhou, T., et al. 2005. Effect of interleukin-10 on the phenotype and function of cultured human dendritic cells. Chin. Med. J. 118:1299-1302.
63. Zhuravskaya, T., et al. 1997. Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency. Blood 90:2482-2491.